---
title: Loss of Dnmt3a increased self-renewal and resistance to pegIFNα in JAK2-V617F-positive
  myeloproliferative neoplasms
date: '2024-03-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38493481/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240318180743&v=2.18.0.post9+e462414
source: Blood
description: Pegylated interferon alpha (pegIFNα) can induce molecular remissions
  in JAK2-V617F-positive myeloproliferative neoplasms (MPN) patients by targeting
  long-term hematopoietic stem cells (LT-HSCs). Additional somatic mutations in genes
  regulating LT-HSC self-renewal, such as DNMT3A, have been reported to have poorer
  responses to pegIFNα. We investigated if DNMT3A loss leads to alterations in JAK2-V617F
  LT-HSCs functions conferring resistance to pegIFNα treatment in a mouse model of
  MPN and ...
disable_comments: true
---
Pegylated interferon alpha (pegIFNα) can induce molecular remissions in JAK2-V617F-positive myeloproliferative neoplasms (MPN) patients by targeting long-term hematopoietic stem cells (LT-HSCs). Additional somatic mutations in genes regulating LT-HSC self-renewal, such as DNMT3A, have been reported to have poorer responses to pegIFNα. We investigated if DNMT3A loss leads to alterations in JAK2-V617F LT-HSCs functions conferring resistance to pegIFNα treatment in a mouse model of MPN and ...